Meagan Jacoby, M.D., Ph.D.
Washington University School of Medicine
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Meagan Jacoby, M.D., Ph.D. as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:05 UTC. Open this list on ClinicalTrials.gov
- N/ANCT04986657 · Whole Genome Sequencing (ChromoSeq) as an Adjunct to Conventional Genomic Profiling in AML and MDSWashington University School of Medicine · recruiting · Whole Genome Sequencing, Acute Myeloid Leukemia, Myelodysplastic Syndromes · principal investigator
- Ph1/Ph2NCT04742634 · Pre-emptive Therapy With DEC-C to Improve Outcomes in MDS Patients With Measurable Residual Disease Post Allogeneic Hematopoietic Cell TransplantWashington University School of Medicine · recruiting · Myelodysplastic Syndromes · principal investigator
- Ph1NCT03572764 · CPX-351 (Vyxeos™) for Transplant Eligible, Higher Risk Patients With Myelodysplastic SyndromeWashington University School of Medicine · active not recruiting · Myelodysplastic Syndromes · principal investigator
- Ph2NCT02756962 · Improving Risk Assessment of AML With a Precision Genomic Strategy to Assess Mutation ClearanceWashington University School of Medicine · active not recruiting · Acute Myeloid Leukemia · principal investigator
- Ph2NCT02112045 · A Study of Granix to Disrupt the Bone Marrow Microenvironment in Patients With Multiple Myeloma Undergoing Autologous TransplantationWashington University School of Medicine · terminated · Multiple Myeloma · principal investigator
- Ph1NCT01913951 · Vosaroxin and Azacitidine in Treating Patients With Myelodysplastic SyndromesWashington University School of Medicine · completed · Myelodysplastic Syndromes · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:05 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in acute myeloid leukemia.